Jim Cramer discusses Abbott Laboratories (NYSE:ABT) as a potential play amid COVID concerns. Shares have gained 17% YTD, recovering from an 8% drop in July. Cramer sees potential in ABT and its Binax product. AI stocks may offer higher returns with limited downside. Check our free report on the best short-term AI stock.

Read more at Yahoo Finance: Buy Abbott Laboratories (ABT) If You’re Worried About COVID, Says Jim Cramer